PIPPIN Activators
PIPPIN Activators are a distinct class of chemical compounds that specifically enhance the functional activity of PIPPIN, a protein crucial for cellular processes such as cell proliferation and differentiation. These activators typically enhance PIPPIN activity through specific signaling pathways that PIPPIN is directly involved in, such as the PI3K/AKT pathway and cAMP/PKA pathway. Inositol, LPA, Riluzole, and EGF are compounds that can enhance the function of PIPPIN through the PI3K/AKT pathway. This pathway is key in cell survival, and PIPPIN acts downstream of this pathway. Thus, modulation of the PI3K/AKT pathway can lead to the activation of PIPPIN. LPA and EGF are compounds that can activate the PI3K/AKT pathway, leading to enhanced function of PIPPIN. Riluzole indirectly activates the glutamate receptors, which can lead to activation of the PI3K/AKT pathway, potentially enhancing PIPPIN's function.
Forskolin, IBMX, Cilostazol, and H-89 are compounds that can enhance the function of PIPPIN through the cAMP/PKA pathway. Forskolin is a direct activator of adenylate cyclase, leading to increased cAMP levels and PKA activation. PKA can phosphorylate and activate PIPPIN, enhancing its function. IBMX and Cilostazolare phosphodiesterase inhibitors that raise intracellular cAMP, leading to activation of PKA. Increased PKA activity can phosphorylate PIPPIN, enhancing its function. H-89, on the other hand, is a potent PKA inhibitor. Its inhibition of PKA can lead to alterations in the phosphorylation state of PIPPIN, potentially enhancing its function. U73122 and PIP2 are compounds that can enhance PIPPIN's function through phospholipase C (PLC) and phosphatidylinositol 4,5-bisphosphate (PIP2) related pathways. U73122 is a selective inhibitor of PLC, and its inhibition can increase PIP2 levels. PIPPIN, being a PIP2-binding protein, can have its function enhanced with increased PIP2 levels. PIP2 itself is directly involved in the activation of PIPPIN, and increased PIP2 can bind to and enhance the function of PIPPIN.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
myo-Inositol | 87-89-8 | sc-202714 sc-202714A sc-202714B sc-202714C | 100 g 250 g 1 kg 5 kg | $80.00 $151.00 $275.00 $837.00 | ||
Inositol is involved in the PI3K/AKT pathway. This pathway is key in cell survival. Enhanced PI3K/AKT signaling can lead to increased activity of PIPPIN by maintaining an environment favorable for its function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a direct activator of adenylate cyclase, resulting in increased cAMP levels and PKA activation. PKA can phosphorylate and activate PIPPIN, enhancing its function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which elevate intracellular cAMP levels and activate PKA. Increased PKA activity can enhance the function of PIPPIN by activating it via phosphorylation. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic Acid (LPA) activates the LPA receptor, which can activate the downstream PI3K/AKT pathway. Activation of this pathway may lead to the enhanced function of PIPPIN. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
Riluzole indirectly activates the glutamate receptors, which can lead to activation of the PI3K/AKT pathway, potentially enhancing the function of PIPPIN. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Cilostazol is a phosphodiesterase III inhibitor that raises intracellular cAMP, leading to activation of PKA. Increased PKA activity can phosphorylate PIPPIN, enhancing its function. | ||||||